Newsletter | April 3, 2024

04.03.24 -- 2 Ways To Encourage Investor Funding

SPONSOR

Webinar: An Introduction To One Home For Sites - Help Build The Only Industry-Wide Solution To Clinical Trial Tech Overload

Increasing technology demands on clinical research sites have led to technology overload resulting in sites struggling with less capacity to run trials. Join us in this webinar to explore how to alleviate the burden on sites and still gain the benefits being delivered by clinical technology innovators. Click here to learn more.

DECENTRALIZED TRIALS

Why Jane Myles Believes DCTs Are “Completely Doable”

From The Editor | By Dan Schell, Chief Editor, Clinical Leader

If you want to know about how perceptions regarding DCTs are changing, talk with Jane Myles of the DTRA (Decentralized Trials & Research Alliance). As Program Director at DTRA, she is acutely aware of all the challenges and opportunities surrounding anything with the term “decentralized trial.”

The Rise, Fall, And Eventual Rebound Of Decentralized Clinical Trials

Guest Column | By Nael Abdelsamad, MD, MBA, FACHE, CPI

First, there was skepticism, then enthusiasm, and then disillusionment. DCTs have had their ups and downs. Here, we're looking ahead to the future of DCTs.

Data-Driven Adaptive Trials Enhance Safety, Progress, And Economics

Article | By Chris Driver, IQVIA Technologies

By offering guidance on optimizing ROI from extensive data collections and various endpoints in clinical studies, learn how IRT technology can enhance the data-driven approach for sponsors.

DCTs: Balancing Patient Accessibility With Data Reliability

Article | By Christina Dinger, ThoughtSphere

Discover why ongoing dialogue and scrutiny are essential to strike a balance between patient-centered initiatives and the methodological rigor necessary for credible and reliable results.

TRIAL MANAGEMENT

2 Ways To Encourage Investor Funding

Guest Column | By Sergey Jakimov and Artem A. Trotsyuk, Ph.D., LongeVC

Biotechs should consider these two promising funding models that balance risk with reward: clinical trial-specific fundraising and staged funding release.

Global Prevalence And Clinical Trials Landscape Of DMD

Article | Novotech

Stay informed with the latest advancements in the fight against Duchenne Muscular Dystrophy, a disease that impacts thousands of lives worldwide.

Optimizing Cell Therapy Supply Chains For Success

E-Book | Catalent

When it comes to transporting highly sensitive and valuable materials, such as cell therapies, learn how teams can ensure that unique storage and distribution requirements are met.

Decision-Making For Adopting A 'Bring Your Own Device' Strategy

White Paper | By Estelle Haenel, Kayentis

Set explicit expectations about what "bring your own device" strategies should be, and the associated risks, and propose structured help to support successful decision-making processes and implementation.

Roche Cuts Feasibility Process By 36%

Case Study | Cognizant

Uncover how an industry pioneer and veteran biotech benefited from this solution after struggling with complexity and consistency when it came to its approach to clinical trial feasibility.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Wednesday edition of the Clinical Leader newsletter, focusing on Decentralized Trials and Trial Management. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: